Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Citations Over TimeTop 1% of 2015 papers

Abstract

Polycystic ovary syndrome (PCOS) is a common, highly heritable complex disorder of unknown aetiology characterized by hyperandrogenism, chronic anovulation and defects in glucose homeostasis. Increased luteinizing hormone relative to follicle-stimulating hormone secretion, insulin resistance and developmental exposure to androgens are hypothesized to play a causal role in PCOS. Here we map common genetic susceptibility loci in European ancestry women for the National Institutes of Health PCOS phenotype, which confers the highest risk for metabolic morbidities, as well as reproductive hormone levels. Three loci reach genome-wide significance in the case-control meta-analysis, two novel loci mapping to chr 8p23.1 [Corrected] and chr 11p14.1, and a chr 9q22.32 locus previously found in Chinese PCOS. The same chr 11p14.1 SNP, rs11031006, in the region of the follicle-stimulating hormone B polypeptide (FSHB) gene strongly associates with PCOS diagnosis and luteinizing hormone levels. These findings implicate neuroendocrine changes in disease pathogenesis.

Related Papers

• → Polycystic ovary syndrome in obese adolescents(2008)36 cited
• → The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome(1989)102 cited
• Gherlin expression in women with polycystic ovary syndrome--a preliminary study.(2005)
• → Serum asprosin level in different subtypes of polycystic ovary syndrome: a cross-sectional study(2021)9 cited
• → Differential activity of the corticosteroidogenic enzymes in normal cycling women and women with polycystic ovary syndrome(2019)6 cited